Analyst Reco. Virbac

Equities

VIRP

FR0000031577

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:24 2025-06-18 am EDT			5-day change	1st Jan Change
319.00 ^EUR	+0.63%		-1.54%	+0.79%

Apr. 16	VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway
Apr. 16	VIRBAC : Stifel still buying after Q1 results	CF

Analyst Reco.

VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway	Apr. 16
VIRBAC : Stifel still buying after Q1 results	Apr. 16	CF
VIRBAC : Oddo BHF remains 'neutral', confirms its target	Mar. 17	CF
VIRBAC : 2024 profitability somewhat exceeded expectations; stock re-rating underway	Mar. 17
VIRBAC : Stifel raises its recommendation	Mar. 17	CF
VIRBAC : 2024 top-line goals met; uninspiring 2025 outlook could be raised later	Jan. 17
Oddo BHF Downgrades Virbac to Neutral, Cuts PT	Jan. 17	MT
VIRBAC : Market’s anxiety over the Q3 miss was not warranted	24-10-18
VIRBAC : Making good strides	24-10-01
TP ICAP Midcap Upgrades Virbac to Buy	24-07-30	MT
VIRBAC : Robust Q2 was already baked in after the recent guidance upgrade	24-07-17
VIRBAC : Virbac remains an attractive animal healthcare play	24-05-03
VIRBAC : A healthy start to 2024; outlook re-iterated	24-04-17
VIRBAC : Modest beat in Q4; 2024 outlook maintained	24-01-18
Stifel Keeps Virbac at Hold, Boosts PT	24-01-18	MT
VIRBAC : Onboarding some steady improvements	23-12-22
VIRBAC : On course for a better-than-expected 2023 finish	23-12-20
Oddo BHF Keeps Virbac at Outperform, Boosts PT	23-12-20	MT
VIRBAC : Factoring in the improved 2023 outlook	23-10-26
VIRBAC : A rebound in Q3; outlook improved; markets jubilant	23-10-24
Oddo BHF Upgrades Virbac to Outperform from Neutral, Lifts PT	23-10-24	MT
VIRBAC : H1 profitability pressure less severe than expected	23-10-03
Stifel Downgrades Virbac to Keep from Buy, Cuts PT	23-08-21	MT
VIRBAC : In line Q2; markets coming to terms with the previously-moderated guidance	23-07-19
VIRBAC : Capacity constraints (temporary?) and a market slowdown weigh on near-term earnings	23-07-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway

April 16, 2025 at 07:58 am EDT